ATIC Antikörper (AA 310-550)
Kurzübersicht für ATIC Antikörper (AA 310-550) (ABIN1886357)
Target
Alle ATIC Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 310-550
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 310 and 550 of ATIC
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ATIC (5-Aminoimidazole-4-Carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase (ATIC))
-
Andere Bezeichnung
- ATIC
-
Hintergrund
-
This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway.The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity.A mutation in this gene results in AICA-ribosiduria.[provided by RefSeq]
Synonyms: AICAR, AICARFT, FLJ93545, IMPCHASE, PURH -
Molekulargewicht
- 65 kDa
-
Gen-ID
- 471
-
NCBI Accession
- NP_004035, NM_004044
Target
-